NCT00485589View on ClinicalTrials.gov

A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate (FILM)

PHASE3TerminatedINTERVENTIONAL

Enrollment

613

Participants

Timeline

Start Date

June 11, 2007

Primary Completion Date

January 29, 2010

Study Completion Date

August 29, 2013

Conditions

Rheumatoid Arthritis

Interventions

DRUG

Methotrexate

Oral repeating dose

DRUG

Ocrelizumab

Intravenous repeating dose

DRUG

Placebo

Intravenous repeating dose

Sponsors

Lead Sponsor

Genentech, Inc.

All Listed Sponsors

collaborator

Roche Pharma AG

INDUSTRY

lead

Genentech, Inc.

INDUSTRY

NCT00485589 - A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate (FILM) | Biotech Hunter | Biotech Hunter